Evidence map›Paper›PMID 29293563›Full record

ArticlePloS one2018

Vibrio cholerae O1 secretes an extracellular matrix in response to antibody-mediated agglutination.

Danielle E Baranova, Kara J Levinson, Nicholas J Mantis

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Recombinant Human Secretory IgA InducesACS infectious diseases · 2021
    Article
  9. Article
  10. Aptamer-nanobody based ELASA for detection ofIranian journal of microbiology · 2020
    Article
  11. Article
  12. Passive Immunity toPathogens & immunity · 2020
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Danielle E BaranovaDepartment of Biomedical Sciences, University at Albany, Albany, NY, United States of America.
Kara J LevinsonDepartment of Biomedical Sciences, University at Albany, Albany, NY, United States of America.
Nicholas J MantisDepartment of Biomedical Sciences, University at Albany, Albany, NY, United States of America.ORCID 0000-0002-5083-8640
New York State Department of Health · US

Funding

Mechanisms of IgA - mediated immunity to Vibrio choleraeR21AI109275 · NIAID · WADSWORTH CENTER · PI MANTIS, NICHOLAS J. · 2016 to 2017
$451k
NIAID NIH HHS R21 AI109275NIH HHS R21-AI109275
6 · The paper itself

Abstract

Vibrio cholerae O1 is one of two serogroups responsible for epidemic cholera, a severe watery diarrhea that occurs after the bacterium colonizes the human small intestine and secretes a potent ADP-ribosylating toxin. Immunity to cholera is associated with intestinal anti-lipopolysaccharide (LPS) antibodies, which are known to inhibit V. cholerae motility and promote bacterial cell-cell crosslinking and aggregation. Here we report that V. cholerae O1 classical and El Tor biotypes produce an extracellular matrix (ECM) when forcibly immobilized and agglutinated by ZAC-3 IgG, an intestinally-derived monoclonal antibody (MAb) against the core/lipid A region of LPS. ECM secretion, as demonstrated by crystal violet staining and scanning electron microscopy, occurred within 30 minutes of antibody exposure and peaked by 3 hours. Non-motile mutants of V. cholerae did not secrete ECM following ZAC-3 IgG exposure, even though they were susceptible to agglutination. The ECM was enriched in O-specific polysaccharide (OSP) but not Vibrio polysaccharide (VPS). Finally, we demonstrate that ECM production by V. cholerae in response to ZAC-3 IgG was associated with bacterial resistant to a secondary complement-mediated attack. In summary, we propose that V. cholerae O1, upon encountering anti-LPS antibodies in the intestinal lumen, secretes an ECM (or O-antigen capsule) possibly as a strategy to shield itself from additional host immune factors and to exit an otherwise inhospitable host environment.

Indexed as

Extracellular MatrixAgglutination TestsEnzyme-Linked Immunosorbent AssayHumansImmunoglobulin GMicroscopy, Electron, ScanningO AntigensVibrio cholerae O1Immunoglobulin GO Antigens

Identifiers

PMID29293563
PMCPMC5749738
OpenAlexW2782117725

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.